Monk Fruit Recall Alert: FDA Says You Might Be Eating Stevia Instead
A sweetener swap you didn't sign up for just got the FDA's second-highest risk warning.
Bottles of monk fruit and stevia from NuNaturals, Inc. were accidentally mislabeled—meaning you might be spooning the wrong sweetener into your coffee. The company issued a voluntary nationwide recall on July 14, and the FDA officially classified it as a Class II recall on August 1.
So, what actually happened?
NEWS ALERT🚨: RECALL FOR ORGANIC FOODS…AGAIN!Recall for Organic Pure Stevia and Pure Monk Fruit Sweetener on July 14. The FDA later issued a Class II risk classification for the recall on August 1. pic.twitter.com/5WXylgvcg4
— Norman Buntz (@normanbuntzhsb) August 7, 2025
In short: the labels got swapped. Some bottles labeled Pure Monk Fruit Sweetener were actually filled with stevia, and some labeled Organic Pure Stevia had monk fruit inside instead.
According to NuNaturals, 78 bottles of each product are affected. Both share lot number 25104S and a best-by date of April 2028. The monk fruit version has UPC 7 39223 00187 6 (0.71 oz), and the stevia version has UPC 7 39223 00204 0 (1 oz). All were packaged in plastic bottles with white caps and sold nationwide.
🎬 SIGN UP for Parade's Daily newsletter to get the latest pop culture news & celebrity interviews delivered right to your inbox 🎬
The FDA's website says a Class II recall is issued when 'use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.'
In other words, it's not likely to be life-threatening, but it's still something to take seriously, especially if you have allergies.
People who are sensitive to ragweed and related plants may also react to stevia—a risk flagged by Verywell Health. Monk fruit allergies are rare, but not impossible. The Independent notes that reactions can range from mild irritation to more serious issues like anaphylaxis.
💪 SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week 💪
This isn't the only label mix-up the FDA's flagged recently. On July 30, High Noon recalled some vodka seltzers that were accidentally labeled as non-alcoholic Celsius energy drinks, due to a packaging mix-up with a shared supplier.
And just a couple of weeks earlier, Bunge North America pulled 64,800 pounds of its NH European Style Butter Blend after the label failed to list milk, a major allergen. That recall was later upgraded to Class II by the FDA on July 30.
Monk Fruit Recall Alert: FDA Says You Might Be Eating Stevia Instead first appeared on Parade on Aug 7, 2025
This story was originally reported by Parade on Aug 7, 2025, where it first appeared.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
US FDA says country's IV, injectable saline shortage is resolved
(Reuters) -A shortage of intravenous and injectable saline solutions in the United States has now been resolved, U.S. Food and Drug Administration commissioner Martin Makary said on Friday. A shortage of IV fluids, which provide nutrients to the body or replenish fluids lost due to injury or illness, had forced hospitals to curtail elective procedures last year. The shortage partly stems from Baxter International's North Carolina plant getting damaged in Hurricane Helene in September. At that time, the Marion, North Carolina site was producing 60% of the nation's supply of IV fluids and peritoneal dialysis solutions, amounting to 1.5 million bags daily, according to the American Hospital Association. Baxter and the FDA did not immediately respond to Reuters' requests for comment. Germany's Fresenius and B. Braun Medical had ramped up their production to help mitigate these shortages, while Baxter worked with the FDA to import some intravenous products. Last week, the company said demand remained subdued, even as supply stabilized. In May, Baxter said inventory levels at its North Carolina facility had been fully restored. The FDA said it is working closely with manufacturers and will continue to monitor the supply of other IV fluids, which are still in shortage. Hurricane Helene struck the Florida Gulf Coast in late September, ripping up roads, destroying homes, severing communication across the southeastern U.S., and leaving hundreds unaccounted for and many confirmed dead. Many hospitals in Florida and Tennessee were forced to evacuate or operate under emergency conditions, while dealing with shortage of resources. Solve the daily Crossword
Yahoo
24 minutes ago
- Yahoo
Why Is Sotera Health Company (SHC) Stock Soaring Today
What Happened? Shares of healthcare services company Sotera Health (NASDAQ:) jumped 20% in the morning session after the company reported strong second-quarter 2025 results that surpassed analyst expectations and raised its full-year financial outlook. The healthcare sterilization and lab testing provider announced second-quarter adjusted earnings per share of $0.20, beating analyst estimates of $0.17. Revenue for the quarter came in at $294.3 million, a 6.4% year-over-year increase, which also surpassed the consensus estimate of $275.6 million. The company's profitability also improved, with adjusted EBITDA (a measure of operational profitability) of $150.7 million, beating analyst forecasts by 9.8%. Following the strong performance, Sotera Health raised its full-year 2025 guidance, increasing its forecast for adjusted earnings per share by 7.5% to $0.78 at the midpoint. Is now the time to buy Sotera Health Company? Access our full analysis report here, it's free. What Is The Market Telling Us Sotera Health Company's shares are somewhat volatile and have had 10 moves greater than 5% over the last year. But moves this big are rare even for Sotera Health Company and indicate this news significantly impacted the market's perception of the business. The previous big move we wrote about was 18 days ago when the stock gained 3.4% amid broader positive market sentiment ahead of a busy week for corporate earnings. U.S. stock futures indicated a higher open for the markets, setting a positive tone for investors who were anticipating a heavy slate of earnings reports from major companies during the week. Notably, the earnings season got off to a strong start: More than 85% of the S&P 500 stocks that reported earnings exceeded expectations, according to FactSet data. This robust performance fueled positive sentiment, suggesting that corporate profitability remained resilient despite ongoing economic uncertainties. Sotera Health Company is down 1.4% since the beginning of the year, and at $13.43 per share, it is trading 20.6% below its 52-week high of $16.91 from September 2024. Investors who bought $1,000 worth of Sotera Health Company's shares at the IPO in November 2020 would now be looking at an investment worth $534.90. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Yahoo
24 minutes ago
- Yahoo
Supplement kratom faces safety concerns: "It's ruining people's lives"
There's growing concern about the safety of consuming a supplement known as kratom, derived from the leaves of a tree native to Southeast Asia that has exploded in popularity in recent years. Used in a variety of products — including drinks, pills, powders and brewed tea leaves — kratom is marketed as an energy booster, relaxant and pain reliever. But it's increasingly blamed for addiction, seizures and in some instances deaths. Kratom is currently banned in six states and Washington, D.C., and at least 18 states have some form of regulation. "There's a common misperception that because it's plant-based ... it's safe or non-addictive, but for kratom that's absolutely not true," said Matthew Rossheim, who researches intoxicating substances. He said he thinks kratom products are too accessible and lack proper warnings on their labels. The FDA has warned consumers not to use kratom, citing risks including substance use disorder, seizures and even death, primarily when mixed with other substances like alcohol. Last week, Health and Human Services Secretary Robert F. Kennedy Jr. announced plans for a crackdown on one kratom compound. "It's ruining people's lives" Jasmine Adeoye, 29, tells CBS News she became hooked on a kratom beverage. While quitting alcohol, she says she became addicted to the drink Feel Free Classic, which contains kratom and is manufactured and sold by Botanic Tonics. She said she heard about it on a podcast. "You're advertised this alcohol alternative, so you feel like it's something totally safe and you start to believe there's something wrong with you when you become addicted to this," she said. Feel Free, like other kratom-based products, is readily available at many convenience stores, largely without regulation or oversight. Adeoye is now using social media to warn others. "There's a lot of people who are struggling in silence and really need help, and it's ruining people's lives for sure," she said. The American Kratom Association told CBS News that it advocates for regulations that aim to keep dangerous kratom products off the market. This includes labeling requirements and bans on kratom sales to minors. Kratom-related lawsuits There have been dozens of wrongful death lawsuits across the country related to kratom. In 2023, a class action lawsuit was filed against Botanic Tonics, alleging Feel Free was misleadingly advertised as a safe alcohol alternative. Instead, the suit claimed it was highly addictive and marketed to people struggling with sobriety. Botanic Tonics has since settled the lawsuit. They told CBS News in a statement they "deeply regret any confusion or harm past marketing may have caused" and say they now provide comprehensive information about their products, including intake limits and clear safety warnings. Global stock markets react to Trump's sweeping tariffs in effect now Sean "Diddy" Combs wants to go back to Madison Square Garden in the future, attorney says Why Trump is calling for Intel CEO's immediate resignation Solve the daily Crossword